#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Palmar-plantar erythrodysaesthesia syndrome Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Graft versus host disease Neurotrophic keratopathy Neuroblastoma Infantile spasms Acute respiratory distress syndrome Aicardi-Goutieres syndrome Oesophageal atresia Leiomyosarcoma recurrent Factor VIII deficiency Paget's disease of the vulva Myxoid liposarcoma Chronic kidney disease Familial haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Haemophilia – Basic Information Mantle cell lymphoma stage IV – Life with Disease Ehlers-Danlos syndrome Castleman’s disease – Basic Information Urea cycle disorder – Life with Disease Angelman’s syndrome – Basic Information Wiskott-Aldrich syndrome – Life with Disease Osteosarcoma metastatic – Basic Information Ewing’s sarcoma – Diagnostics Lymphangiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-LEUCINE Azd7798 Fosaprepitant DESMOPRESSIN ACETATE Ganaxolone Tropicamide Lacutamab Deupirfenidone Rapcabtagene Autoleucel Mirikizumab Dapagliflozin Regtivex Ponesimod Ferumoxytol HLX43 Navitoclax 1,3-BUTYLENE GLYCOL Zinc Acexamate Azd0901 Belumosudil Mesilate More therapies…

    Learn about Your Condition

    Wolfram syndrome Primary biliary cholangitis Myelodysplastic syndrome Infertility female Breast proliferative changes K-ras gene mutation Mumps Leiomyosarcoma metastatic Antithrombin III deficiency Encephalopathy neonatal Colon cancer stage IV Astrocytoma malignant Embolism Endometrial adenocarcinoma Pathogen resistance More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Plasma cell myeloma

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Iberdomide
    • Dexamethasone Acetate
    Belgium France

  • Study on Heparin Sodium and Sodium Chloride for Patients with Lymphoma or Myeloma Undergoing Stem Cell Collection

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lymphoma
    • Plasma cell myeloma
    Investigated Drugs:
    • Heparin Sodium
    • Sodium Chloride
    Sweden

  • Study on Alnuctamab and Mezigdomide for Patients with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Alnuctamab
    • Mezigdomide
    • Dexamethasone
    Denmark

  • Study on Daratumumab, Carfilzomib, Pomalidomide, and Dexamethasone for Patients with Multiple Myeloma and Acute Kidney Failure

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Carfilzomib
    • Daratumumab
    • Dexamethasone
    Austria

  • Efficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    • Dexamethasone Ph. Eur.
    • Dexamethasone
    Belgium Bulgaria France Germany Greece Hungary +4

  • Study on the Safety and Effectiveness of Anitocabtagene Autoleucel and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Anitocabtagene Autoleucel
    • Isatuximab
    • Fludarabine
    Spain
Previous Page
1 … 8 9 10 11 12 … 27
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!